Published: February 2022
While there had been great resilience in the face of pandemic-induced uncertainties during the last few years, 2022 saw a globally concerted effort to unshackle the effects of the pandemic. Since 2020, organizations have faced challenges and developed various strategies to overcome the impact of COVID-19 and their business loss. Although this has affected the market on a larger scale, Life Sciences companies found themselves amongst the frontrunners in the revival story.
Aon's APAC Life Sciences Compensation Trends Webinar recently concluded on 10th February, 2022 which covers:
Talk to us Subscribe
The information contained herein and the statements expressed are of a general nature and are not intended to address the circumstances of any particular individual or entity. Although we endeavor to provide accurate and timely information and use sources we consider reliable, there can be no guarantee that such information is accurate as of the date it is received or that it will continue to be accurate in the future. No one should act on such information without appropriate professional advice after a thorough examination of the particular situation.
The contents herein may not be reproduced, reused, reprinted or redistributed without the expressed written consent of Aon, unless otherwise authorized by Aon. To use information contained herein, please write to our team.
Let us know how we can help and a member of our team will be in touch shortly.
Aon group companies will use your personal information to contact you from time to time about other products, services and events that we feel may be of interest to you. All personal information is collected and used in accordance with our privacy statement.
If you do not wish to receive these communications, please check here: